Surface-enhanced raman scattering-based immunoassay technologies for detection of disease biomarkers

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Detection of biomarkers is of vital importance in disease detection, management,and monitoring of therapeutic efficacy. Extensive efforts have been devoted to the development of novel diagnostic methods that detect and quantify biomarkers with higher sensitivity and reliability,contributing to better disease diagnosis and prognosis. When it comes to such devastating diseases as cancer, these novel powerful methods allow for disease staging as well as detection of cancer at very early stages. Over the past decade, there have been some advances in the development of platforms for biomarker detection of diseases. The main focus has recently shifted to the development of simple and reliable diagnostic tests that are inexpensive, accurate, and can follow a patient's disease progression and therapy response. The individualized approach in biomarker detection has been also emphasized with detection of multiple biomarkers in body fluids such as blood and urine. This review article covers the developments in Surface-Enhanced Raman Scattering (SERS) and related technologies with the primary focus on immunoassays. Limitations and advantages of the SERS-based immunoassay platform are discussed. The article thoroughly describes all components of the SERS immunoassay and highlights the superior capabilities of SERS readout strategy such as high sensitivity and simultaneous detection of a multitude of biomarkers. Finally, it introduces recently developed strategies for in vivo biomarker detection using SERS.

Original languageEnglish (US)
Article number7
JournalBiosensors
Volume7
Issue number1
DOIs
StatePublished - Jan 12 2017

Fingerprint

Raman Spectrum Analysis
Biomarkers
Immunoassay
Raman scattering
Technology
Body fluids
Body Fluids
Disease Management
Routine Diagnostic Tests
Disease Progression
Neoplasms
Blood
Urine
Monitoring
Therapeutics

Keywords

  • Biomarkers
  • Immunoassay
  • Nanodiagnostics
  • Surface-enhanced raman scattering

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Surface-enhanced raman scattering-based immunoassay technologies for detection of disease biomarkers. / Smolsky, Joseph; Kaur, Sukwinder; Hayashi, Chihiro; Batra, Surinder Kumar; Krasnoslobodtsev, Alexey V.

In: Biosensors, Vol. 7, No. 1, 7, 12.01.2017.

Research output: Contribution to journalReview article

@article{63ef505a41964c71944aaa459d27c300,
title = "Surface-enhanced raman scattering-based immunoassay technologies for detection of disease biomarkers",
abstract = "Detection of biomarkers is of vital importance in disease detection, management,and monitoring of therapeutic efficacy. Extensive efforts have been devoted to the development of novel diagnostic methods that detect and quantify biomarkers with higher sensitivity and reliability,contributing to better disease diagnosis and prognosis. When it comes to such devastating diseases as cancer, these novel powerful methods allow for disease staging as well as detection of cancer at very early stages. Over the past decade, there have been some advances in the development of platforms for biomarker detection of diseases. The main focus has recently shifted to the development of simple and reliable diagnostic tests that are inexpensive, accurate, and can follow a patient's disease progression and therapy response. The individualized approach in biomarker detection has been also emphasized with detection of multiple biomarkers in body fluids such as blood and urine. This review article covers the developments in Surface-Enhanced Raman Scattering (SERS) and related technologies with the primary focus on immunoassays. Limitations and advantages of the SERS-based immunoassay platform are discussed. The article thoroughly describes all components of the SERS immunoassay and highlights the superior capabilities of SERS readout strategy such as high sensitivity and simultaneous detection of a multitude of biomarkers. Finally, it introduces recently developed strategies for in vivo biomarker detection using SERS.",
keywords = "Biomarkers, Immunoassay, Nanodiagnostics, Surface-enhanced raman scattering",
author = "Joseph Smolsky and Sukwinder Kaur and Chihiro Hayashi and Batra, {Surinder Kumar} and Krasnoslobodtsev, {Alexey V}",
year = "2017",
month = "1",
day = "12",
doi = "10.3390/bios7010007",
language = "English (US)",
volume = "7",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Surface-enhanced raman scattering-based immunoassay technologies for detection of disease biomarkers

AU - Smolsky, Joseph

AU - Kaur, Sukwinder

AU - Hayashi, Chihiro

AU - Batra, Surinder Kumar

AU - Krasnoslobodtsev, Alexey V

PY - 2017/1/12

Y1 - 2017/1/12

N2 - Detection of biomarkers is of vital importance in disease detection, management,and monitoring of therapeutic efficacy. Extensive efforts have been devoted to the development of novel diagnostic methods that detect and quantify biomarkers with higher sensitivity and reliability,contributing to better disease diagnosis and prognosis. When it comes to such devastating diseases as cancer, these novel powerful methods allow for disease staging as well as detection of cancer at very early stages. Over the past decade, there have been some advances in the development of platforms for biomarker detection of diseases. The main focus has recently shifted to the development of simple and reliable diagnostic tests that are inexpensive, accurate, and can follow a patient's disease progression and therapy response. The individualized approach in biomarker detection has been also emphasized with detection of multiple biomarkers in body fluids such as blood and urine. This review article covers the developments in Surface-Enhanced Raman Scattering (SERS) and related technologies with the primary focus on immunoassays. Limitations and advantages of the SERS-based immunoassay platform are discussed. The article thoroughly describes all components of the SERS immunoassay and highlights the superior capabilities of SERS readout strategy such as high sensitivity and simultaneous detection of a multitude of biomarkers. Finally, it introduces recently developed strategies for in vivo biomarker detection using SERS.

AB - Detection of biomarkers is of vital importance in disease detection, management,and monitoring of therapeutic efficacy. Extensive efforts have been devoted to the development of novel diagnostic methods that detect and quantify biomarkers with higher sensitivity and reliability,contributing to better disease diagnosis and prognosis. When it comes to such devastating diseases as cancer, these novel powerful methods allow for disease staging as well as detection of cancer at very early stages. Over the past decade, there have been some advances in the development of platforms for biomarker detection of diseases. The main focus has recently shifted to the development of simple and reliable diagnostic tests that are inexpensive, accurate, and can follow a patient's disease progression and therapy response. The individualized approach in biomarker detection has been also emphasized with detection of multiple biomarkers in body fluids such as blood and urine. This review article covers the developments in Surface-Enhanced Raman Scattering (SERS) and related technologies with the primary focus on immunoassays. Limitations and advantages of the SERS-based immunoassay platform are discussed. The article thoroughly describes all components of the SERS immunoassay and highlights the superior capabilities of SERS readout strategy such as high sensitivity and simultaneous detection of a multitude of biomarkers. Finally, it introduces recently developed strategies for in vivo biomarker detection using SERS.

KW - Biomarkers

KW - Immunoassay

KW - Nanodiagnostics

KW - Surface-enhanced raman scattering

UR - http://www.scopus.com/inward/record.url?scp=85014069209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014069209&partnerID=8YFLogxK

U2 - 10.3390/bios7010007

DO - 10.3390/bios7010007

M3 - Review article

C2 - 28085088

AN - SCOPUS:85014069209

VL - 7

JO - Biosensors

JF - Biosensors

SN - 0956-5663

IS - 1

M1 - 7

ER -